Michael Molkentin
Plus aucun poste en cours
Profil
Michael Molkentin worked as a Division Controller at Thermo Electron Corp.
and as a Field Controller at Vanstar Corp.
He also worked as a Controller at American Security Resources Corp.
and Computer Automation, Inc. Additionally, he served as a Chief Financial Officer & Secretary at SuperGen, Inc., Aradigm Corp., Astex Therapeutics Ltd., and Astex Pharmaceuticals, Inc. He was also a Principal at Rhode Scripter & Associates.
Molkentin received his undergraduate degree from Baruch College.
Anciens postes connus de Michael Molkentin
| Sociétés | Poste | Fin |
|---|---|---|
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | Directeur Financier/CFO | 01/12/2013 |
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Directeur Financier/CFO | 01/12/2013 |
SuperGen, Inc.
 SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | Directeur Financier/CFO | 13/09/2011 |
| ARADIGM CORPORATION | Directeur Financier/CFO | 01/09/2002 |
Thermo Finnigan Corp.
 Thermo Finnigan Corp. Financial ConglomeratesFinance Part of Thermo Fisher Scientific, Inc., Thermo Finnigan Corp. provides investment services. The company is based in San Jose, CA. | Corporate Officer/Principal | 01/04/2000 |
Formation de Michael Molkentin
| Baruch College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BITCOIN CRYPTO CURRENCY EXCHANGE CORP | Technology Services |
| Entreprise privées | 10 |
|---|---|
Thermo Electron Corp.
 Thermo Electron Corp. Electronic Equipment/InstrumentsElectronic Technology Thermo Electron Corporation is a worldwide provider of analytical instruments, scientific equipment, services and software solutions for life science, drug discovery, clinical, environmental and industrial laboratories, as well as for use in a variety of manufacturing processes and in-the-field applications, including those associated with safety and homeland security | Electronic Technology |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | Health Technology |
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
Vanstar Corp.
 Vanstar Corp. Miscellaneous Commercial ServicesCommercial Services Vanstar Corp. is a gold exploration company with properties located in northern Quebec. Vanstar also owns 100% of the Felix property under development in the Chicobi group and 100% of Amanda, a 7,679 ha property located on the Auclair formation with historic gold showings up to 12.1 g/t Au over 3 meters. The company is based in Canada. The American company owns a 25% interest in the Nelligan project, which won the "Discovery of the Year" award at the 2019 Quebec Mineral Exploration Association Xplor Gala. Vanstar was acquired by InaCom Corp. on February 17, 1999 for $436.07 million. | Commercial Services |
Computer Automation, Inc.
 Computer Automation, Inc. Electronic Equipment/InstrumentsElectronic Technology Computer Automation, Inc. develops test systems for circuit boards. The private company is based in Richardson, TX and has subsidiaries in the United States. | Electronic Technology |
Rhode Scripter & Associates
 Rhode Scripter & Associates Miscellaneous Commercial ServicesCommercial Services Part of CBIZ, Inc., Rhode Scripter & Associates provides accounting services. The company is based in Boulder, CO. Rhode Scripter & Associates was acquired by CBIZ, Inc. on September 22, 1998. | Commercial Services |
Astex Therapeutics Ltd.
Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Thermo Finnigan Corp.
Thermo Finnigan Corp. Financial ConglomeratesFinance Part of Thermo Fisher Scientific, Inc., Thermo Finnigan Corp. provides investment services. The company is based in San Jose, CA. | Finance |
| Republic Telcom Systems, Inc. | |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Health Technology |
